Logo image of SATS

ECHOSTAR CORP-A (SATS) Stock Fundamental Analysis

NASDAQ:SATS - Nasdaq - US2787681061 - Common Stock - Currency: USD

28.93  -0.16 (-0.55%)

After market: 28.93 0 (0%)

Fundamental Rating

2

SATS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 97 industry peers in the Media industry. Both the profitability and financial health of SATS have multiple concerns. SATS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SATS had negative earnings in the past year.
In the past year SATS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SATS reported negative net income in multiple years.
Each year in the past 5 years SATS had a positive operating cash flow.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

SATS's Return On Assets of -0.35% is in line compared to the rest of the industry. SATS outperforms 54.64% of its industry peers.
SATS has a Return On Equity of -1.07%. This is comparable to the rest of the industry: SATS outperforms 53.61% of its industry peers.
Industry RankSector Rank
ROA -0.35%
ROE -1.07%
ROIC N/A
ROA(3y)-0.11%
ROA(5y)0.06%
ROE(3y)-1.37%
ROE(5y)-0.61%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

The Gross Margin of SATS (25.23%) is worse than 72.16% of its industry peers.
In the last couple of years the Gross Margin of SATS has declined.
The Profit Margin and Operating Margin are not available for SATS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.93%
GM growth 5Y-15.16%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SATS has more shares outstanding
The number of shares outstanding for SATS has been increased compared to 5 years ago.
The debt/assets ratio for SATS is higher compared to a year ago.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

Based on the Altman-Z score of 0.66, we must say that SATS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.66, SATS is in line with its industry, outperforming 40.21% of the companies in the same industry.
SATS has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.27, SATS is not doing good in the industry: 63.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACCN/A
WACC6.8%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

SATS has a Current Ratio of 1.26. This is a normal value and indicates that SATS is financially healthy and should not expect problems in meeting its short term obligations.
SATS's Current ratio of 1.26 is in line compared to the rest of the industry. SATS outperforms 44.33% of its industry peers.
SATS has a Quick Ratio of 1.19. This is a normal value and indicates that SATS is financially healthy and should not expect problems in meeting its short term obligations.
SATS's Quick ratio of 1.19 is in line compared to the rest of the industry. SATS outperforms 44.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

SATS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.00%.
The Revenue for SATS has decreased by -23.85% in the past year. This is quite bad
The Revenue has been growing by 53.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.5%
Revenue 1Y (TTM)-23.85%
Revenue growth 3Y99.75%
Revenue growth 5Y53.02%
Sales Q2Q%-3.61%

3.2 Future

SATS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.94% yearly.
The Revenue is expected to grow by 2.36% on average over the next years.
EPS Next Y-943.86%
EPS Next 2Y-248.3%
EPS Next 3Y-140.34%
EPS Next 5Y0.94%
Revenue Next Year-2.42%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.91%
Revenue Next 5Y2.36%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 6 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SATS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SATS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

SATS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.39
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

SATS's earnings are expected to decrease with -140.34% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-248.3%
EPS Next 3Y-140.34%

More info and screens

0

5. Dividend

5.1 Amount

SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECHOSTAR CORP-A

NASDAQ:SATS (7/17/2025, 8:00:02 PM)

After market: 28.93 0 (0%)

28.93

-0.16 (-0.55%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners88.62%
Inst Owner Change-0.01%
Ins Owners13.01%
Ins Owner Change-0.04%
Market Cap8.31B
Analysts73.85
Price Target29.07 (0.48%)
Short Float %11.09%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)169.49%
Min EPS beat(2)20.7%
Max EPS beat(2)318.29%
EPS beat(4)2
Avg EPS beat(4)28.11%
Min EPS beat(4)-197.05%
Max EPS beat(4)318.29%
EPS beat(8)4
Avg EPS beat(8)-62.75%
EPS beat(12)6
Avg EPS beat(12)-33.51%
EPS beat(16)9
Avg EPS beat(16)8.86%
Revenue beat(2)0
Avg Revenue beat(2)-1.54%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-2.04%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-1.1%
Revenue beat(8)1
Avg Revenue beat(8)-2.96%
Revenue beat(12)3
Avg Revenue beat(12)-2.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.51%
PT rev (1m)-3.39%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.12%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-12.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.59%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF 8.25
P/B 0.42
P/tB 0.42
EV/EBITDA 17.39
EPS(TTM)-0.76
EYN/A
EPS(NY)-5.46
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)3.51
OCFY12.13%
SpS54.56
BVpS69.62
TBVpS69.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -1.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.23%
FCFM N/A
ROA(3y)-0.11%
ROA(5y)0.06%
ROE(3y)-1.37%
ROE(5y)-0.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.93%
GM growth 5Y-15.16%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 16.28
Cap/Depr 66.41%
Cap/Sales 8.19%
Interest Coverage N/A
Cash Conversion 64.79%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 0.66
F-Score4
WACC6.8%
ROIC/WACCN/A
Cap/Depr(3y)116.85%
Cap/Depr(5y)106.37%
Cap/Sales(3y)15.16%
Cap/Sales(5y)18.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.5%
EPS Next Y-943.86%
EPS Next 2Y-248.3%
EPS Next 3Y-140.34%
EPS Next 5Y0.94%
Revenue 1Y (TTM)-23.85%
Revenue growth 3Y99.75%
Revenue growth 5Y53.02%
Sales Q2Q%-3.61%
Revenue Next Year-2.42%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.91%
Revenue Next 5Y2.36%
EBIT growth 1Y-186.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year600.22%
EBIT Next 3Y101.42%
EBIT Next 5Y70.63%
FCF growth 1Y-258.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.78%
OCF growth 3Y25.6%
OCF growth 5Y13.8%